Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Goodyear

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancerStephen Couban, Michael Goodyear, Margot Burnell, et al.
Frontiers in Immunology|February 28, 2022
Immune Regulatory 1 Cells: A Novel and Potent Subset of Human T Regulatory CellsNicolas Krause, Jörg Mengwasser, Elpida Phithak, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancerStephen Couban, Michael Goodyear, Margot Burnell, et al.
Frontiers in Immunology|February 28, 2022
Immune Regulatory 1 Cells: A Novel and Potent Subset of Human T Regulatory CellsNicolas Krause, Jörg Mengwasser, Elpida Phithak, et al.
Pageof 1